tiprankstipranks
Calyx Bio-Ventures Inc (TSE:CYX.H)
TSXV:CYX.H
Canadian Market

Calyx Bio-Ventures (CYX.H) Income Statement

6 Followers

Calyx Bio-Ventures Income Statement

Last quarter (Q ), Calyx Bio-Ventures's total revenue was C$―, a decrease of ― from the same quarter last year. In Q, Calyx Bio-Ventures's net income was C$-133.68K. See Calyx Bio-Ventures’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 18Dec 17Dec 16Dec 15Dec 14
Total Revenue
C$ 200.00C$ 2.40KC$ 93.05KC$ 105.44KC$ 49.27KC$ 0.00
Cost of Revenue
C$ -122.37K-C$ 39.00KC$ 44.30KC$ 16.22KC$ 0.00
Gross Profit
C$ -120.58KC$ 2.40KC$ 54.05KC$ 61.14KC$ 33.05KC$ 0.00
Operating Expense
C$ 779.32KC$ 798.40KC$ 1.11MC$ 755.97KC$ 484.04KC$ 568.28K
Operating Income
C$ -779.12KC$ -796.00KC$ -1.06MC$ -694.83KC$ -450.99KC$ -568.28K
Net Non Operating Interest Income Expense
C$ -743.00-C$ 8.70KC$ -1.37K--
Other Income Expense
C$ -882.26KC$ -883.50KC$ 8.47KC$ -141.00C$ 299.15KC$ 41.29K
Pretax Income
C$ -1.68MC$ -1.68MC$ -1.06MC$ -696.34KC$ -151.85KC$ -526.99K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -2.38MC$ -2.49MC$ -1.45MC$ -696.34KC$ -151.85KC$ -526.99K
Basic EPS
C$ -0.02C$ -0.03C$ -0.02C$ -0.01C$ >-0.01C$ -0.01
Diluted EPS
C$ -0.02C$ -0.03C$ -0.02C$ -0.01C$ >-0.01C$ -0.01
Basic Average Shares
C$ 384.85MC$ 90.23MC$ 63.29MC$ 52.47MC$ 48.76MC$ 38.95M
Diluted Average Shares
C$ 384.85MC$ 90.23MC$ 63.29MC$ 52.47MC$ 48.76MC$ 38.95M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 192.44KC$ -798.40KC$ -1.15MC$ 800.27KC$ 500.26KC$ 568.28K
Net Income From Continuing And Discontinued Operation
C$ -2.38MC$ -2.49MC$ -1.45MC$ -696.34KC$ -151.85KC$ -526.99K
Normalized Income
C$ -1.60MC$ -350.70KC$ -779.54KC$ -696.20KC$ -150.76KC$ -568.28K
Interest Expense
C$ 7.84K--C$ 1.37K--
EBIT
C$ -777.45KC$ -1.68MC$ -1.05MC$ -694.83KC$ -450.99KC$ -568.28K
EBITDA
C$ -701.95KC$ -1.62MC$ -918.45KC$ -556.54KC$ -338.32KC$ -554.89K
Currency in CAD

Calyx Bio-Ventures Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis